CureVac NV (CVAC)
2.91
-0.07
(-2.35%)
USD |
NASDAQ |
May 10, 16:00
2.95
+0.04
(+1.37%)
After-Hours: 20:00
CureVac Gross Profit Margin (Quarterly): -137.5% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -137.5% |
| September 30, 2023 | -47.31% |
| June 30, 2023 | -241.1% |
| March 31, 2023 | -189.5% |
| December 31, 2022 | -584.4% |
| September 30, 2022 | -114.8% |
| June 30, 2022 | -111.9% |
| March 31, 2022 | -52.76% |
| December 31, 2021 | -69.84% |
| September 30, 2021 | -292.0% |
| Date | Value |
|---|---|
| June 30, 2021 | -66.98% |
| March 31, 2021 | -57.13% |
| December 31, 2020 | -17.93% |
| September 30, 2020 | 61.78% |
| June 30, 2020 | |
| March 31, 2020 | -75.54% |
| December 31, 2019 | -33.67% |
| September 30, 2019 | -538.6% |
| March 31, 2019 | -139.5% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-584.4%
Minimum
Dec 2022
61.78%
Maximum
Sep 2020
-151.1%
Average
-75.54%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| Affimed NV | -- |
| InflaRx NV | -12.02K% |
| MorphoSys AG | 75.20% |
| BioNTech SE | 68.50% |
| Immatics NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -43.12% |
| Return on Assets | -29.79% |
| Return on Invested Capital | -43.12% |
| Profit Margin (Quarterly) | -384.0% |
| Operating Margin (Quarterly) | -394.9% |
| Return on Net Operating Assets | -76.14% |